Space
Adventures, a company that provides human space missions to the world marketplace,
has confirmed that their orbital spaceflight client, Richard Garriott, will participate in a suite of experiments in cooperation with NASA during his 10-day
mission.
Mr. Garriott is scheduled to launch on October 12 onboard a Soyuz TMA spacecraft from the Baikonur Cosmodrome in Kazakhstan en route to the
International Space Station (ISS). He will be joining the Expedition 18 crew which includes NASA astronaut Michael Fincke and Russian
cosmonaut Yuri Lonchakov.
“I am enthusiastic to participate in these experiments. As my father was a NASA astronaut, it seems fitting that I, as a private astronaut, also assist
in their research as a continuation of my family’s contribution to the space agency,” said Richard
Garriott.
“Space exploration is of critical importance to our future as a species,”
added Eric Anderson, president and CEO of Space Adventures. “Through
Richard’s gracious participation in these NASA experiments, he will be making an important contribution to the future of human permanence in
space.”
Mr. Garriott will participate in three NASA experiments. The first experiment will study the current microgravity environment encountered by
astronauts and how their eyes react to low and high pressure as well as variations in oxygen concentrations. Mr. Garriott will be the first space
explorer to have had Photorefractive Keratectomy eye surgery, referred to as PRK. NASA has recently approved this procedures for their
astronauts, but to date, none have been flown or have been selected who have had the procedure. NASA will examine his visual acuity,
accommodation and refraction before, during and after spaceflight. There is reason to believe visual acuity might change
in orbit, as inner eye
pressure goes up by as much as 50% during spaceflights. This information will determine if an eye which has undergone a PRK procedure
remains stable during a 10-day exposure to microgravity.
The second experiment will study the effects of spaceflight on the human immune system and validate monitoring tests for immune function in
astronauts. The study will assess immunity during spaceflight by testing white blood cells for changes in function or response to stimulation as a
consequence of spaceflight. This information may determine astronauts’ clinical risk during spaceflight. Previous data collected suggests that
there is indeed a suppression of the immune system associated with spaceflight. Mr. Garriott will be contributing to this data pool, and since his
mission will come mid-mission for some other astronauts; he will be able to return fresh blood samples from long-duration crew members, which
has rarely been able to be sampled.
The third study will document sleep/wake patterns and sleep characteristics of astronauts. Normal sleep patterns and body chemistry are notably
changed during spaceflight. The data collected may assist in determining the efficacy of ongoing countermeasures for space-related sleep
disturbances and may also assist in developing additional countermeasures which could potentially impact the health, productivity and safety of
astronauts during spaceflight.
See
other recent news regarding:
Travel News Asia, Promotions,
New
Hotels, Space
Adventures, Space
Travel
|